Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Enteric Softgel Capsules Market Expansion From $2.55 Billion In 2026 To $3.05 Billion In 2030

The market for enteric softgel capsules has experienced consistent expansion, projected to increase from $2.44 billion in 2025 to $2.55 billion in 2026, reflecting a compound annual growth rate of 4.7%. This upward trend during the past period was fueled by escalating demand for digestive health supplements, a growing preference for oral drug delivery methods, significant advancements in softgel formulation techniques, heightened consumer awareness regarding health and wellness, and ongoing innovation in pharmaceutical dosages.

The market for enteric softgel capsules is projected for consistent expansion in the coming years, anticipating a rise to $3.05 billion by 2030, fueled by a compound annual growth rate of 4.6%. This growth trajectory during the forecast period is anticipated to be bolstered by several key factors, including an increasing demand for vegan capsule options, the burgeoning field of personalized nutrition, advancements in the development of controlled-release formulations, the expanding scope of pharmaceutical outsourcing, and a heightened emphasis on preventive healthcare. Concurrently, prominent market trends expected to shape this period include a growing need for targeted drug delivery systems, an uptick in nutraceutical consumption, a greater utilization of acid-resistant formulations, the broadened acceptance and use of plant-based capsules, and a continuous focus on enhancing bioavailability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20775&type=smp

Enteric Softgel Capsules Market Expansion Supported By Key Demand Factors

Rising instances of nutritional imbalances, stemming from inadequate or excessive intake of vital vitamins, minerals, proteins, fats, and carbohydrates, are projected to be a key catalyst for the expansion of the enteric softgel capsules market. These nutritional disorders are exacerbated by prevalent unhealthy eating patterns, inactive lifestyles, restricted availability of wholesome foods, a greater reliance on processed food products, and socioeconomic hurdles that impede appropriate nourishment. Enteric softgel capsules play a crucial role in addressing these disorders by facilitating the delivery of essential nutrients, safeguarding them from the acidic environment of the stomach and ensuring their phased release within the intestines, thus optimizing absorption, enhancing nutrient bioavailability, and promoting better gastrointestinal function and nutritional equilibrium. As an illustration, a 2024 publication by the Food and Agriculture Organization, a Canada-based international body, highlighted that global undernourishment persisted at 9.1 percent in 2023, with 11.5 percent of the populace experiencing food insecurity during the same year, underscoring the growing demand for solutions like enteric softgel capsules in managing these widespread nutritional challenges.

Enteric Softgel Capsules Market Segment Analysis And Revenue Opportunities

The enteric softgel capsules market covered in this report is segmented –

1) By Type: Gelatin Capsules, Non-Gelatin Softgel Capsules

2) By Distribution Channel: Supermarkets And Hypermarkets, Pharmacy And Drug Stores, Online Stores

3) By Application: Antacid And Antiflatulent Preparations, Anti-Inflammatory Drugs, Antibiotic And Antibacterial Drugs, Cough And Cold Preparations, Health Supplements, Vitamin And Dietary Supplements, Other Therapeutic Applications

4) By End User: Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Food Industry

Subsegments:

1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules, Porcine Gelatin Softgel Capsules, Fish Gelatin Softgel Capsules

2) By Non-Gelatin Softgel Capsules: Plant-Based Softgel Capsules, Vegan Softgel Capsules, Polymer-Based Softgel Capsules

Enteric Softgel Capsules Market Growth Trends Influencing Competitive Dynamics

Within the enteric softgel capsules market, significant players are actively engaged in innovation, specifically concentrating on sophisticated solutions like plant-derived excipient systems designed for intestinal release that are resistant to stomach acid. These advancements aim to boost product stability, enhance the absorption of active compounds, and cater to demands for clean-label and vegan products. A plant-based excipient system, which utilizes polymers not sourced from animals – exemplified by hydroxypropyl pea starch – constructs capsules capable of withstanding gastric acidity and facilitating therapeutic release in the intestinal tract. This contrasts with conventional gelatin softgels, which might dissolve prematurely in the stomach, potentially compromising acid-sensitive ingredients. To illustrate, Roquette, a French provider of plant-based ingredients, introduced LYCAGEL in April 2024. This hydroxypropyl pea starch excipient empowers producers to formulate vegan, clean-label softgels exhibiting acid resistance, thereby safeguarding delicate nutraceuticals like omega-3 fatty acids and probiotics, optimizing bioavailability, and obviating the necessity of gelatin.

Enteric Softgel Capsules Market Leading Players Shaping Industry Direction

Major companies operating in the enteric softgel capsules market are BASF SE, United Laboratories International Inc., Herbalife Nutrition Ltd., Catalent Pharma Solutions Inc., Sirio Pharma Co. Ltd., NOW Health Group Inc., Patheon, GELITA AG, Colorcon Inc., Aenova Group GmbH, ProCaps Laboratories Inc., CAPTEK Softgel International Inc., Renown Pharmaceuticals Private Limited, Viva Pharmaceutical Inc., Biofield Pharma Private Limited, CapsCanada Corporation, Natural Capsules Limited, Fuji Capsules Co. Ltd., Conch Lifescience Co. Ltd., Lonza Group Ltd., EuroCaps Ltd., Strides Pharma Science Limited, Emcure Pharmaceuticals Limited, Soft Gel Technologies Inc.

Access The Complete Enteric Softgel Capsules Market Report:

https://www.thebusinessresearchcompany.com/report/enteric-softgel-capsules-global-market-report

Enteric Softgel Capsules Market Geographic Distribution And Regional Opportunities

North Americawas the largest region in the enteric softgel capsules market in 2025. The regions covered in the enteric softgel capsules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model